References
- Stadelmann WK, Digenis AG, Tobin GR. Impediments to wound healing. Am J Surg 1998;176(2A Suppl):39S-47S.
- Simms M. Surgical treatment of the neuroischemic foot. J Cardiovasc Surg (Torino) 2009;50:293-311.
- Guizzardi S, Galli C, Govoni P, et al. Polydeoxyribonucleotide (PDRN) promotes human osteoblast proliferation: a new proposal for bone tissue repair. Life Sci 2003;73:1973-83. https://doi.org/10.1016/S0024-3205(03)00547-2
- Sini P, Denti A, Cattarini G, et al. Effect of polydeoxyribonucleotides on human fibroblasts in primary culture. Cell Biochem Funct 1999;17:107-14. https://doi.org/10.1002/(SICI)1099-0844(199906)17:2<107::AID-CBF815>3.0.CO;2-#
- Galeano M, Bitto A, Altavilla D, et al. Polydeoxyribonucleotide stimulates angiogenesis and wound healing in the genetically diabetic mouse. Wound Repair Regen 2008;16: 208-17. https://doi.org/10.1111/j.1524-475X.2008.00361.x
- Bitto A, Galeano M, Squadrito F, et al. Polydeoxyribonucleotide improves angiogenesis and wound healing in experimental thermal injury. Crit Care Med 2008;36:1594-602. https://doi.org/10.1097/CCM.0b013e318170ab5c
- Polito F, Bitto A, Galeano M, et al. Polydeoxyribonucleotide restores blood flow in an experimental model of ischemic skin flaps. J Vasc Surg 2012;55:479-88. https://doi.org/10.1016/j.jvs.2011.07.083
- Bitto A, Polito F, Altavilla D, et al. Polydeoxyribonucleotide (PDRN) restores blood flow in an experimental model of peripheral artery occlusive disease. J Vasc Surg 2008;48: 1292-300. https://doi.org/10.1016/j.jvs.2008.06.041
- Brander VA, Gomberawalla A, Chambers M, et al. Efficacy and safety of hylan G-F 20 for symptomatic glenohumeral osteoarthritis: a prospective, pilot study. Pm r 2010;2:259-67. https://doi.org/10.1016/j.pmrj.2010.02.010
- Kim JY, Pak CS. Effects of polydeoxyribonucleotide in the treatment of pressure ulcers. J Korean Med Sci 2014;29 Suppl 3:S222-7. https://doi.org/10.3346/jkms.2014.29.S3.S222
- Squadrito F, Bitto A, Altavilla D, et al. The effect of PDRN, an adenosine receptor A2A agonist, on the healing of chronic diabetic foot ulcers: results of a clinical trial. J Clin Endocrinol Metab 2014;99:E746-53. https://doi.org/10.1210/jc.2013-3569
- Tellechea A, Kafanas A, Leal EC, et al. Increased skin inflammation and blood vessel density in human and experimental diabetes. Int J Low Extrem Wounds 2013;12:4-11. https://doi.org/10.1177/1534734612474303
- Cheong H, Kang H, Kim HK, et al. Microvessel and lymphatic vessel density and VEGFR-3 expression of papillary thyroid carcinoma with comparative analysis of clinicopathological characteristics. Korean J Pathol 2010;44:243-51. https://doi.org/10.4132/KoreanJPathol.2010.44.3.243
- Altavilla D, Bitto A, Polito F, et al. Polydeoxyribonucleotide (PDRN): a safe approach to induce therapeutic angiogenesis in peripheral artery occlusive disease and in diabetic foot ulcers. Cardiovasc Hematol Agents Med Chem 2009;7:313-21. https://doi.org/10.2174/187152509789541909
- Lazzarotto M, Tomasello EM, Caporossi A. Clinical evaluation of corneal epithelialization after photorefractive keratectomy in patients treated with polydeoxyribonucleotide (PDRN) eye drops: a randomized, double-blind, placebo-controlled trial. Eur J Ophthalmol 2004;14:284-9. https://doi.org/10.1177/112067210401400402
- Montesinos MC, Desai A, Chen JF, et al. Adenosine promotes wound healing and mediates angiogenesis in response to tissue injury via occupancy of A(2A) receptors. Am J Pathol 2002;160:2009-18. https://doi.org/10.1016/S0002-9440(10)61151-0
- Gurunluoglu R, Meirer R, Shafighi M, et al. Gene therapy with adenovirus-mediated VEGF enhances skin flap prefabrication. Microsurgery 2005;25:433-41. https://doi.org/10.1002/micr.20142
- Hasko G, Linden J, Cronstein B, et al. Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat Rev Drug Discov 2008;7:759-70. https://doi.org/10.1038/nrd2638
Cited by
- Ultrasound-Guided Prolotherapy with Polydeoxyribonucleotide for Painful Rotator Cuff Tendinopathy vol.2018, pp.None, 2018, https://doi.org/10.1155/2018/8286190
- Aesthetic soft tissue management in facial trauma vol.61, pp.12, 2017, https://doi.org/10.5124/jkma.2018.61.12.715
- Influence of SIRT1 polymorphisms for diabetic foot susceptibility and severity vol.97, pp.28, 2017, https://doi.org/10.1097/md.0000000000011455
- Polydeoxyribonucleotide, as a Novel Approach for the Management of Medication-Related Osteonecrosis of the Jaw: A Preliminary Observational Study vol.11, pp.2, 2017, https://doi.org/10.5856/jkds.2018.11.2.57
- The Effect of Polydeoxyribonucleotide Extracted from Salmon Sperm on the Restoration of Bisphosphonate-Related Osteonecrosis of the Jaw vol.17, pp.1, 2019, https://doi.org/10.3390/md17010051
- Effect of Polydeoxyribonucleotide on Chondrocutaneous Composite Grafts Survival vol.43, pp.4, 2019, https://doi.org/10.1007/s00266-019-01400-x
- Purinergic Signaling During Hyperglycemia in Vascular Smooth Muscle Cells vol.11, pp.None, 2017, https://doi.org/10.3389/fendo.2020.00329
- The effects of polydeoxyribonucleotide on wound healing and tissue regeneration: a systematic review of the literature vol.15, pp.6, 2017, https://doi.org/10.2217/rme-2019-0118
- Mitigating osteonecrosis of the jaw (ONJ) through preventive dental care and understanding of risk factors vol.8, pp.1, 2017, https://doi.org/10.1038/s41413-020-0088-1
- Polydeoxyribonucleotide-delivering therapeutic hydrogel for diabetic wound healing vol.10, pp.1, 2020, https://doi.org/10.1038/s41598-020-74004-0
- Non-surgical treatment for pressure ulcer vol.64, pp.1, 2021, https://doi.org/10.5124/jkma.2021.64.1.26
- Alginate/chitosan-based hydrogel loaded with gene vectors to deliver polydeoxyribonucleotide for effective wound healing vol.9, pp.16, 2017, https://doi.org/10.1039/d1bm00911g
- Polydeoxyribonucleotide: A Promising Biological Platform to Accelerate Impaired Skin Wound Healing vol.14, pp.11, 2017, https://doi.org/10.3390/ph14111103